Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 1/20 | 0.38 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.38 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.38 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.37 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23493307 | 0.92 | DNM1 (0.45) | DNM1SPHK1TSHRALDH1A1 | |
| SCHEMBL11788651 | 0.90 | DNM1 (0.48) | DNM1SPHK1TSHR | |
| SCHEMBL23493308 | 0.90 | DNM1 (0.48) | DNM1SPHK1TSHR | |
| SCHEMBL132624 | 0.83 | — | — | |
| SCHEMBL19774902 | 0.83 | DNM1 (0.31) | ADRB2ADRB1ADRB3DNM1 | |
| SCHEMBL1559166 | 0.79 | ADRB2 (0.38) | ADRB2ADRB1ADRB3DNM1SPHK1 | |
| SCHEMBL11877454 | 0.78 | CA1 (0.40) | DNM1SPHK1TSHRCA1CA2 | |
| SCHEMBL6667445 | 0.77 | SPHK1 (0.37) | ADRB2ADRB1ADRB3DNM1SPHK1 | |
| SCHEMBL9586905 | 0.77 | ADRB2 (0.36) | ADRB2ADRB1ADRB3DNM1TSHR | |
| SCHEMBL8808198 | 0.75 | SPHK1 (0.40) | ADRB2ADRB1ADRB3DNM1SPHK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 107 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119823092-A | Vinyl sulfate compound, synthesis method and application thereof in secondary battery | 江苏华盛锂电材料股份有限公司 | 2025-04-15 | — | — | CN | claimed |
| CN-103030598-B | The preparation method of methoxy acrylic bactericide | SHANGHAI HEBEN PHARMACEUTICAL CO., LTD. (CN) | 2016-04-13 | — | — | CN | claimed |
| CN-103626691-B | The preparation method of ZEN 90160 | Shanghai Heben-Eastsun Medicaments Co., Ltd. (CN) | 2015-10-21 | — | — | CN | claimed |
| CN-104151233-A | Preparation method of agricultural bactericide | ZHEJIANG TIDE CROP TECHNOLOGY CO LTD | 2014-11-19 | — | — | CN | claimed |
| CN-103626691-A | Picoxystrobin preparation method | SHANGHAI HEBEN EASTSUN MEDICAMENTS CO LTD | 2014-03-12 | — | — | CN | claimed |
| CN-103030598-A | Method for preparing strobilurin fungicide | SHANGHAI HEBEN EASTSUN MEDICAMENTS CO LTD | 2013-04-10 | — | — | CN | claimed |
| US-20080308426-A1 | Electrochemical Method for the Production of Betulin Aldehyde | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2008-12-18 | — | — | US | claimed |
| WO-2006105357-A2 | ELECTROCHEMICAL METHOD FOR THE PRODUCTION OF BETULIN ALDEHYDE | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2006-10-05 | — | — | WO | claimed |
| US-20250215030-A1 | STAT MODULATORS AND USES THEREOF | RECLUDIX PHARMA, INC. | 2025-07-03 | — | — | US | disclosed |
| US-20250179103-A1 | 6-OXODECAHYDROPYRROLO[1,2-A][1,5]DIAZOCINE AND 6-OXODECAHYDRO-4H-PYRROLO[2,1-D][1,5]THIAZOCINE DERIVATIVES AS STAT3 AND STAT6 MODULATORS FOR THE TREATMENT OF CANCER AND INFLAMMATORY CONDITIONS | RECLUDIX PHARMA, INC. | 2025-06-05 | — | — | US | disclosed |
| CN-115268215-B | Photosensitive polyimide resin composition, photosensitive polyimide film containing photosensitive polyimide resin composition and application of photosensitive polyimide film | 吉林奥来德光电材料股份有限公司 | 2025-05-16 | — | — | CN | disclosed |
| CN-119823092-A | Vinyl sulfate compound, synthesis method and application thereof in secondary battery | 江苏华盛锂电材料股份有限公司 | 2025-04-15 | — | — | CN | disclosed |
| EP-4499656-A1 | STAT MODULATORS AND USES THEREOF | Recludix Pharma, Inc. (US) | 2025-02-05 | — | — | EP | disclosed |
| US-12216113-B2 | Method for preparing analysis sample, analysis method, and kit for preparing analysis sample | SHIMADZU CORPORATION (JP) | 2025-02-04 | — | — | US | disclosed |
| US-4521422-A | ANTICONVULSANT, ANTIEPILEPTIC AGENTS, SEDATIVES, MUSCLE RELAXANTS | AMERICAN CYANAMID COMPANY (US) | 1985-06-04 | — | — | US | disclosed |
| EP-0129847-A2 | Aryl and heteroaryl[7-(aryl and heteroaryl)-pyrazolo-[1,5-a]-pyrimidin-3-yl]methanones | AMERICAN CYANAMID COMPANY (US) | 1985-01-02 | — | — | EP | disclosed |
| US-4175087-A | ENAMINOKETONES WITH ALKYLLITHIUM | ELI LILLY AND COMPANY (US) | 1979-11-20 | — | — | US | disclosed |
| US-4146627-A | AMINOALKYLIDEAMINO-1,4-DIHYDROPYRIDINES AND THEIR USE AS MEDICAMENTS | BAYER AKTIENGESELLSCHAFT (DE) | 1979-03-27 | — | — | US | disclosed |
| US-4130715-A | Tricyclic trisaminomethanes | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1978-12-19 | — | — | US | disclosed |
| US-4085106-A | Bicyclic and tricyclic trisaminomethanes | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1978-04-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250179103-A1 | 6-OXODECAHYDROPYRROLO[1,2-A][1,5]DIAZOCINE AND 6-OXODECAHYDRO-4H-PYRROLO[2,1-D][1,5]THIAZOCINE DERIVATIVES AS STAT3 AND STAT6 MODULATORS FOR THE TREATMENT OF CANCER AND INFLAMMATORY CONDITIONS | STAT6, STAT3, STAT1 | ADRB2 2867/4885ADRB1 2188/4885ADRB3 3577/4885 |
| US-20250215030-A1 | STAT MODULATORS AND USES THEREOF | STAT6, STAT3, STAT5A | ADRB2 3165/4885ADRB1 2685/4885ADRB3 3144/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.